![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
Advertisement
Persons > All
Please find below persons from Ireland & the United Kingdom (GB) or related to organisations from these countries.Total search results: 4893 | Ordered by Person (descending)
1 2 3 4 ... 47 48 49 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| White, Janet (Lonza 201109 Head Development Services) | President/Director/Head Business Group/Unit/Division | Lonza (Group) | Northwestern Switzerland (region) |
| White, James (Osmetech 200511 CEO) | Chief Executive Officer (CEO) | Roche (Group) | Greater London (region) |
| White, Colin (Perceptive Instruments 201311 Managing Director) | Managing Director | Instem (Group) | East of England (region) |
| White, Amanda (Health Data Research UK 201807 Director of Communications + Marketing) | Public Relations Manager / Investor Relations Manager | Health Data Research UK | Greater London (region) |
| Whitcombe, David (Dxs 200812 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Qiagen (Group) | North West England (region) |
| Whitaker, Paul (Biosilta 201604 Managing Director) | Managing Director | BioSilta (Group) | East of England (region) |
| Whileman, David (Inflexion 202301 Head of Partnership Capital) | Investment Manager | Inflexion (Group) | Greater London (region) |
| Whetton, Tony (Univ Manchester 201510 Prof + Director of Stoller Biomarker Discovery Center) | Professor | University of Manchester (UoM) | North West England (region) |
| Whelan, Kate (Notch Communications 201108 COO) | Chief Executive Officer (CEO) | Notch Communications AB | Uppsala (region) |
| Wheeler, Paul (Lumicks 202107– CCO before Luminex + Merck + PRW Bioscience + Singulex + Gyros + Guava Technologies) | Chief Commercial Officer (CCO) | Lumicks (Group) | North Holland (province, NL) |
| Wheeler, Patrick (ACD/Labs 201408 NMR Product Manager) | Product Manager (personnel) | Advanced Chemistry Development (ACD/Labs) (Group) | Ontario |
| Wheeler, Jeremy (BioCaptiva 202204– CEO) | Chief Executive Officer (CEO) | BioCaptiva Ltd. | Scotland |
| Wheeler, Alannah (Biosynth 202309 Marketing) | Sales Manager / Marketing Manager | Biosynth (since 9/22) (Group) | Switzerland_other |
| Wetzel, Bernd (SR Pharma 200507 non-executive Director) | Board member, non-executive | Silence Therapeutics (Group) | Greater London (region) |
| Wetekam, Volker (General Electric 201205– CEO + President of GE Healthcare Germany before AGFA HealthCare + Siemens) | Chief Executive Officer (CEO) | General Electric (Group) | South East England (region) |
| Westrop, Rod (Axordia 200610 Commercial Director) | n. a. | Axordia Ltd. | Yorkshire and the Humber (region) |
| Westphal, Christopher (Sirtris 200603 CEO + co-founder before Alnylam CEO + co-founder + Momenta CEO + co-founder) | Chief Executive Officer (CEO) | GSK (Group) | Massachusetts (federal state) |
| Weston, Nick (Agenix 201308 CEO) | Chief Executive Officer (CEO) | Agenix (Group) | Australia_ooo |
| Wester, Per (Alzinova 201601 CEO) | Chief Executive Officer (CEO) | Alzinova AB (publ) | Västra Götaland |
| Westby, Mike (Agalimmune 201406 CEO) | Chief Executive Officer (CEO) | BioLineRx (Group) | Greater London (region) |
| West, Will (CellCentric –200710– CEO + Morningside Ventures 202109) | Chief Executive Officer (CEO) | CellCentric Ltd. | East of England (region) |
| West, Stuart (Biocatalysts Ltd 201803 Managing Director) | Managing Director | BRAIN Biotech (Group) | Wales |
| Wessels, Alexander (DSM 201210 CEO of DSM Pharmaceutical Products) | Chief Executive Officer (CEO) | DSM (Group) | Netherlands_o |
| Wertz, Brad (GenomOncology 202208 CEO) | Chief Executive Officer (CEO) | GenomOncology LLC (GO) | Ohio (federal state) |
| Werner, Thomas (Board Member of several companies before GSK SVP) | Board member, non-executive | GSK (Group) | Greater London (region) |
| Wentworth, James (Transgene 202401– CBO before Adaptimmune + inVentiv Health + Shire + ViroPharma) | Chief Business Officer (CBO) | Mérieux (Group) | Grand Est (Great East) (region) |
| Welten, Harry (Cytos Biotechnology 201203 CFO) | Chief Financial Officer (CFO) | Kuros (Group) | Zürich (region) |
| Welsh, Chris (Consilium Strategic Communications 201707) | Public Relations Manager / Investor Relations Manager | ICR (Group) | Greater London (region) |
| Wells, Glenn (Wellcome Trust 200809 BusDev Manager) | Business Development Manager / Strategy Manager | Wellcome Trust, The | Greater London (region) |
| Weisswasser, Sigal (T.B.N. Group 201201 President + Founder) | President/Director/Head Business Group/Unit/Division | T.B.N. Group (Technology Business Networks) (Group) | Israel_o |
| Weiss, Andrew C. (Idorsia 201706– SVP + Head Investor Relations + Corporate Communications before Actelion) | Public Relations Manager / Investor Relations Manager | Idorsia (Group) | Northwestern Switzerland (region) |
| Weir, Neil (Sitryx Therapeutics 201804– CEO before UCB SVP Discovery) | Chief Executive Officer (CEO) | Sitryx Therapeutics Ltd. | South East England (region) |
| Weir, Malcolm (Heptares 2007– CEO + co-founder before Inpharmatica 2000–2006 CEO before GSK/Glaxo since 1983) | Chief Executive Officer (CEO) | Sosei (Group) | East of England (region) |
| Weinstein, Edward (Horizon Discovery 201607 President of Services Business) | President/Director/Head Business Group/Unit/Division | PerkinElmer (Group) | East of England (region) |
| Weinberger, Paul (Lumora 201005– Chief Marketing Officer before Roche Diagnostics + Enigma Diagnostics) | Sales Manager / Marketing Manager | Erba Diagnostics Mannheim (Group) | East of England (region) |
| Weikert, Gunnar (Inventages Venture Capital 201609 Founder) | Company Founder | Inventages Venture Capital Investments Inc. | Région Lémanique (region) |
| Wei, Liangshen (Horizon Discovery 201611 Head of Emerging Markets Team) | Business Development Manager / Strategy Manager | PerkinElmer (Group) | East of England (region) |
| Weedon, Dimitrios (OrbiMed 202305– Managing Director in new London Office) | Managing Director | OrbiMed (Group) | Greater London (region) |
| Wedlake, Bill (NextPharma 200301– CEO before CFO since 7/00) | Chief Executive Officer (CEO) | NextPharma (Group) | South East England (region) |
| Weber, Olaf (Bayer 201910 Head Radiology RnD) | n. a. | Bayer (Group) | Nordrhein-Westfalen (federal state) |
| Weber, Christophe (Takeda 201504– CEO joined as COO 4/14 before GSK 201305 President GSK Vaccines) | Chief Executive Officer (CEO) | Takeda (Group) | Kinki (region) |
| Webber, Guy (Quotient Bioresearch 201003 Head of In Vitro Sciences) | n. a. | Quotient Bioresearch (Group) | East of England (region) |
| Webb, Mike (Delta Diagnostics (UK) 201310– Operations Director + Co-owner before Hologic + Gen-Probe + Tepnel) | General Manager (management) | Yourgene Health (Group) | North West England (region) |
| Webb, Andrew (EKF Diagnostics 201303– CEO of EKF Molecular Diagnostics before Qiagen/DxS + Amersham Pharmacia Biotech) | Chief Executive Officer (CEO) | EKF Diagnostics (Group) | Greater London (region) |
| Weaver, Tom (Congenica 201309– CEO before MRC + Source BioScience formerly Medical Solutions + Geneservice) | Chief Executive Officer (CEO) | Congenica (Group) | East of England (region) |
| Weaver, Richard (XenoGesis 201109– Managing Director + Founder before AstraZeneca R&D) | Managing Director | Sygnature Discovery (Group) | East Midlands (region) |
| Weaver, Aaron (Apeiron Investment 202110 Principal) | Principal (venture capital) | ANGERMAYER Group (Apeiron Investment Group/Presight Ventures) (family of Christian Angermayer) | Malta_o |
| Watts, Tim (Oxford BioMedica 2012–201709 CFO RETIRED 9/17) | Chief Financial Officer (CFO) | Oxford Biomedica (Group) | South East England (region) |
| Watts, Sam (Stratophase 201110 Business Development + Commercial Officer + co-founder) | Business Development Manager / Strategy Manager | Stratophase Ltd. | South East England (region) |
| Watts, Ryan (Denali Therapeutics 201608 CEO) | Chief Executive Officer (CEO) | Denali Therapeutics (Group) | California (federal state) |
| Watts, Richard (Qiagen 201004– Director Pharma Business Development before Pharma Regional Marketing Manager) | Business Development Manager / Strategy Manager | Qiagen (Group) | Nordrhein-Westfalen (federal state) |
| Watt, Fiona (Univ Cambridge 201203 Professor of Molecular Genetics) | Professor | University of Cambridge | East of England (region) |
| Watt, Alan (NodThera Ltd 201806 CSO + acting CEO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | NodThera Ltd. | East of England (region) |
| Watson, Tim (Instinctif Partners 201807) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | Greater London (region) |
| Watson, Nicola (Schauenburg 201412 at Markes international) | n. a. | Schauenburg (Group) | Wales |
| Watson, Michael (VaxEquity 202109 Executive Chairman) | Board member, executive | VaxEquity Ltd. (VXT) | East of England (region) |
| Watson, Lorna (Northbank Communications 200608 Senior Account Manager) | n. a. | Instinctif Partners (Group) | Greater London (region) |
| Watson, David (Lhasa Ltd 201302 CEO) | Chief Executive Officer (CEO) | Lhasa Ltd. | Yorkshire and the Humber (region) |
| Watson, Dave (Univ Strathclyde 201003 Prof + ScotMet) | Professor | University of Strathclyde (Glasgow) | Scotland |
| Watkins, H. Thomas (HGSI 200512 CEO) | Chief Executive Officer (CEO) | GSK (Group) | Maryland (federal state) |
| Watkin, David J. (Univ Oxford 201009 Dept Chemistry Director Chemical Crystallography Lab) | Researcher (university / research institute) | University of Oxford | United Kingdom (state/region unspecified) |
| Waterworth, Toby Wilson (Atlantic Healthcare plc 201603 CEO) | Chief Executive Officer (CEO) | Atlantic Healthcare plc | East of England (region) |
| Waterman, Sally (OBN 2014–201812 Board Chairman) | Board member, non-executive | OBN (UK) Ltd. | South East England (region) |
| Waterhouse, Oliver J. (Base Genomics 201907– CEO + Founder) | Chief Executive Officer (CEO) | Exact Sciences (Group) | South East England (region) |
| Waterhouse, Deborah (ViiV Healthcare 201907 CEO) | Chief Executive Officer (CEO) | GSK (Group) | Greater London (region) |
| Waterfield, Nick R. (Warwick Univ Medical School 202012 + Co-Founder NanoSyrinx) | Professor | University of Warwick | West Midlands (region) |
| Waterfield, Mike (Piramed 200605 Co-founder) | Company Founder | Roche (Group) | South East England (region) |
| Wass, Ed (Catapult Ventures 201509) | Investment Manager | Catapult Ventures (Group) | East Midlands (region) |
| Warren, Lee (RoslinCT 202204– CFO before Cobra Biologics) | Chief Financial Officer (CFO) | RoslinCT (Group) | Scotland |
| Warren, Katie (Sciad Communications 202011) | Public Relations Manager / Investor Relations Manager | Sciad Communications Ltd. | Greater London (region) |
| Warren, Jeremy (NanoSight Ltd 201309 CEO) | Chief Executive Officer (CEO) | Spectris (Group) | South West England (region) |
| Warners, Morgan (WPP 201811 at Glover Park Group) | Public Relations Manager / Investor Relations Manager | WPP (Group) | |
| Warne, Mark (IP Group 201411 Healthcare Portfolio Director + Activiomics 201004 Interim CEO) | Investment Manager | IP Group (Group) | Greater London (region) |
| Warmuth, Markus (Monte Rosa Therapeutics 202009 CEO + Venture Partner at Versant Ventures before Eisai/H3 Biomedicine) | Chief Executive Officer (CEO) | Monte Rosa Therapeutics (Group) | Massachusetts (federal state) |
| Warme, Louise (Werfen 202402 Head of We Venture Capital) | Investment Manager | Werfen (Group) | Spain_o |
| Warier, Prashant (Qure.ai 202203 CEO + Co-Founder) | Chief Executive Officer (CEO) | Qure.ai (Group) | Maharashtra |
| Warffemius, Pierre (SynCo Bio Partners 201105 CEO) | Chief Executive Officer (CEO) | Wacker (Group) | North Holland (province, NL) |
| Wareing, Clare (Cumulus Oncology 202002 CEO + Founder) | Chief Executive Officer (CEO) | Cumulus Oncology Ltd. | Scotland |
| Wardle, Kay (Coulter Partners 201712) | Human Resources Manager | Coulter Partners (The Coulter Partnership Ltd.) | Greater London (region) |
| Ward-Lilley, James (Vectura 201603 CEO) | Chief Executive Officer (CEO) | Vectura (Group) | South West England (region) |
| Ward, Sean (Synthace 201708 CTO) | Chief Technology/Technical Officer (CTO) | Synthace (Group) | Greater London (region) |
| Ward, Penelope (Virion Biotherapeutics 201811– CMO before UCB + GSK + Roche + Pharmacia & Upjohn) | Chief Medical Officer (CMO) | Virion Biotherapeutics Ltd. | Greater London (region) |
| Ward, Neil (Pacific Biosciences 202106– VP + General Manager EMEA before 13y at Illumina before Agilent) | General Manager (management) | Pacific Biosciences (PacBio) (Group) | California (federal state) |
| Ward, Maya (Gresham House 202104 Associate Director at Gresham House Ventures) | Investment Manager | Gresham House (Group) | Greater London (region) |
| Ward, Malcolm (Proteome Sciences 201009 CTO) | Chief Technology/Technical Officer (CTO) | Proteome Sciences (Group) | South East England (region) |
| Ward, Chris (StrataStem 202306 CSO + Co-Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | ||
| Ward, Barrie (Board Member at several companies in 2012 before CEO of Kudos) | Board member, non-executive | CellCentric Ltd. | East of England (region) |
| Ward, Andrew (FTI Consulting 201808) | Public Relations Manager / Investor Relations Manager | FTI Consulting (Group) | Greater London (region) |
| Warburton, Mark (Cyprotex 201608 COO + Legal Counsel) | Chief Operating Officer (COO) | Evotec (Group) | North West England (region) |
| Warburton, Elaine (QuantuMDx 200803– CEO + Co-founder before Opaldia CEO) | Chief Executive Officer (CEO) | QuantuMDx (Group) | North East England (region) |
| Wanner, Sarah-Christine (Bayer 202003 External Innovation + Partnering) | n. a. | Bayer (Group) | Berlin (federal state) |
| Wang, Zilong (Allen) (HEL Group 202302– promoted to General Manager of H.E.L. China before Malvern Pananalytical) | General Manager (management) | HEL (H.E.L.) (Group) | Beijing (Peking) (province) |
| Wang, Yongdong (Cerno Bioscience 200903 President) | Chief Executive Officer (CEO) | Cerno Bioscience LLC | Connecticut (federal state) |
| Wang, Wenyong (Adaptimmune 201604– VP Business Development before Evolution Life Science Partners + Burrill Secutiries) | Business Development Manager / Strategy Manager | Adaptimmune (Group) | South East England (region) |
| Wang, Elise (Deerfield Management 201808 Principal) | Principal (venture capital) | Deerfield (Group) | New York (federal state) |
| Wandersee, Christian (Vasopharm GmbH 201306 Managing Director) | Managing Director | Vasopharm GmbH | Bayern (federal state) |
| Wanchoo, Vishal (GE Healthcare 200509 CEO of GE Healthcare Information Technologies) | Chief Executive Officer (CEO) | General Electric (Group) | |
| Wambutt, Rolf (AGOWA 200503) | n. a. | LGC (Group) | Berlin (federal state) |
| Walts, Alan (Advent Life Sciences 201702 Venture Partner) | Partner (venture partner) | Advent Life Sciences LLP | Greater London (region) |
| Walton, Luke (Univ Warwick 201905 International Press Manager) | Public Relations Manager / Investor Relations Manager | University of Warwick | West Midlands (region) |
1 2 3 4 ... 47 48 49
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
